N(6)-carboxymethyllysine
N(6)-carboxymethyllysine (CML), also known as N(6)-(carboxymethyl)lysine, is an advanced glycation end-product (AGE) that is formed during the Maillard reaction. It is a non-enzymatic reaction between reducing sugars and amino acids, proteins, or lipids. CML is one of the most abundant and well-studied AGEs.
Formation and Structure[edit | edit source]
CML is formed through the Maillard reaction, a non-enzymatic browning reaction that occurs during cooking and processing of foods. The reaction begins with the condensation of a reducing sugar and an amino group, forming a Schiff base. This base then undergoes rearrangement to form an Amadori product, which can further react to form various AGEs, including CML.
The structure of CML consists of a lysine residue that has been modified by the addition of a carboxymethyl group at the 6 position of the lysine amino acid. This modification results in a molecule with increased polarity and reactivity compared to the original lysine residue.
Biological Significance[edit | edit source]
CML is a major AGE that accumulates in human tissues during aging and under conditions of oxidative stress and inflammation. It has been implicated in the pathogenesis of several age-related diseases, including diabetes, cardiovascular disease, Alzheimer's disease, and kidney disease.
CML can interact with specific cell surface receptors, such as the receptor for advanced glycation end products (RAGE), leading to the activation of intracellular signaling pathways and the production of pro-inflammatory and pro-oxidant molecules. This can contribute to tissue damage and disease progression.
Detection and Measurement[edit | edit source]
CML can be detected and quantified in biological samples using various analytical techniques, such as immunoassays, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods allow for the measurement of CML in blood, urine, and tissue samples, providing a means to assess AGE accumulation in the body.
See Also[edit | edit source]
- Advanced glycation end-product
- Maillard reaction
- Diabetes
- Cardiovascular disease
- Alzheimer's disease
- Kidney disease
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD